自拟益肾健脾化瘀方治疗绝经后脾肾阳虚型骨质疏松症的临床研究

黄琳玲; 吴娟; 邓颖辉

自拟益肾健脾化瘀方治疗绝经后脾肾阳虚型骨质疏松症的临床研究

1.
江西省妇幼保健院妇科，江西南昌 330006
2.
江西省妇幼保健院病理科，江西南昌 330006

计量
- 文章访问数: 1245
- HTML全文浏览量: 3
- PDF下载量: 1128
- 被引次数: 0
出版历程
- 收稿日期: 2017-06-06
- 修回日期: 2017-07-14
- 刊出日期: 2017-09-10

Clinical Curative Effects Analysis of Self-made Yishen Jianpi Huayu Formula in the Treatment of Syndrome of Spleen and Kidney Yang Deficiency of Postmenopausal Osteoporosis

1.
Gynecology of Jiangxi Maternal and Child Health Hospital, Nanchang, 330006, China
2.
Pathology department of Jiangxi Maternal and Child Health Hospital, Nanchang, 330006, China

摘要

摘要: 目的探讨自拟益肾健脾化瘀方治疗绝经后脾肾阳虚型骨质疏松症的临床疗效。方法选取2016年1月-2017年1月我院收治的120例绝经后骨质疏松症患者，将其按照随机数字法随机分为观察组和对照组，每组60例，2组均给予碳酸钙D3片，在此基础上，对照组给予仙灵骨葆胶囊，观察组给予自拟益肾健脾化瘀方剂，2组均治疗3月。结果治疗后2组腰背疼痛、腰膝酸软、夜尿增加、畏寒肢冷、神疲倦怠及总评分均显著下降（P<0.01），但观察组下降更为明显（P<0.01）；治疗后观察组总有效率为93.33%，显著高于对照组（80.00%，P<0.01）；2组腰椎L2~L4、股骨颈、股骨大转子、Ward's三角骨密度均较治疗前显著增加（P<0.01），但观察组增加更为明显（P<0.01）；2组骨特异性碱性磷酸酶（B-ALP）、抗酒石酸酸性磷酸酶（TRACP）均较治疗前显著下降（P<0.01），观察组下降更为明显（P<0.01）；2组雌二醇（E₂）、胰岛素生长因子（IGF-1）均较治疗前显著上升（P<0.01），观察组上升更为明显（P<0.01）;2组患者不良反应发生率比较差异无统计学意义（P>0.05）。结论采用自拟益肾健脾化瘀方可以显著改善绝经后脾肾阳虚型骨质疏松症的临床症状，同时可改善患者骨代谢和骨密度，其作用机制可能与提高雌激素和IGF-1水平有关。
- 自拟益肾健脾化瘀方 /
- 绝经后骨质疏松症 /
- 临床疗效
Abstract: OBJECTIVE To study the Clinical curative effect of self-made Yishen Jianpi Huayu Formula in the treatment of syndrome of spleen and kidney yang deficiency of postmenopausal osteoporosis. METHODS From January 2016 to January 2017， 120 postmenopausal osteoporosis patients included in our hospital were selected and randomly divided into the observation group and the control group by random number， 60 cases in each group. Both groups were given calcium carbonate D3 tablets. On the basis of this， the control group was given xianlinggubao capsules， and the observation group was given self-made Yishen Jianpi Huayu Formula. Both groups were treated for three months. RESULTS After treatment， the total clinical symptoms cores of lumbar and back pain， soreness and weakness of waist and knees， increasing of night urine， aversion to cold and cold limbs and lassitude in both groups were decreased significantly(P<0.01)， but the observation group decreased more significantly (P<0.01). After treatment， the total effective rate in the observation group was 93.33%， which was significantly higher than that in the control group (80.00%， P<0.01). The bone mineral density of lumbar spine， L2~L4， femoral neck， greater trochanter of femur and Ward's pyramidal bone were significantly increased compared with pretreatment (P<0.01)， but the observation group increased more significantly (P<0.01). Bone specific alkaline phosphatase (B-ALP) and tartrate resistant acid phosphatase(TRACP) in both group were decreased significantly (P<0.01) compared with pretreatment， but the observation group decreased more significantly (P<0.01). Estradiol (E₂)， insulin growth factor (IGF-1) in both group were increased significantly compared with pretreatment (P<0.01)， and the observation group increased more significantly (P<0.01). The adverse events occurrence rates in both groups had no significant difference (P＞0.05). CONCLUSION Self-made Yishen Jianpi Huayu formula can significantly improve the clinical symptoms of postmenopausal osteoporosis， and improve patients' bone metabolism and bone mineral density at the same time. Its action mechanism may be associated with increased estrogen and IGF-1 levels.
- self-made Yishen Jianpi Huayu formula /
- postmenopausal osteoporosis /
- clinical effect

HTML全文

参考文献(18)

[1]	赵庆，唐宇星，杨中萌. 骨化三醇与阿伦磷酸钠联用对绝经后骨质疏松症患者的临床疗效评价[J]. 抗感染药学，2015，10(6): 905-907.
[2]	ZHAO Q， TANG YX， YANG ZM. Clinical effects evaluation of combined calcitriol and alendronate sodium in the treatment of postmenopausal osteoporosis[J]. Anti-Infect Pharm， 2015，10(6):905-907.
[3]	赵玺，赵文，孙璟，等. 骨代谢指标与骨关节炎及绝经后骨质疏松症的关系[J]. 中国组织工程研究，2014，18（2）:245-250.
[4]	ZHAO X， ZHAO W， SUN J， et al. Correlation of bone metabolic index with osteoarthritis and postmenopausal osteoporosis[J]. J Clin Rehabil Tis Eng Res， 2014， 18(2):245-250.
[5]	谢丽华，陈娟，许惠娟，等. 绝经后骨质疏松症肾阴虚证差异表达基因CLCF1蛋白表达研究[J]. 中国骨质疏松杂志，2015，21(12): 1425-1428.
[6]	XIE LH， CHEN J， XU HJ， et al. Analysis of the differential expression of the genetic protein CLCF1 in postmenopausal osteoporosis patients with kidney Yin deficiency[J]. Chin J Osteopor， 2015， 21(12):1425-1428.
[7]	朱汉民. 《原发性骨质疏松症诊疗指南》解读[J]. 国际内分泌代谢杂志，2006，26(5):289-294.
[8]	ZHU HM. Understanding and explanation of Chinese guideline on prevention and treatment of primary osteoporosis[J]. Int J Endocrinol Metab， 2006， 26(5):289-294.
[9]	国家中医药管理局. 中医病证诊断疗效标准[S]. 南京:南京大学出版社，1994:7.
[10]	State Administration of Traditional Chinese Medicine. TCM Syndrome Diagnosis and Treatment Criteria[S]. Nanjing: Nanjing university press， 1994:7.
[11]	中华人民共和国卫生部. 中药新药临床研究指导原则[M]. 北京:中国医药科技出版社，2002:116-119．
[12]	Ministry of Health， PRC. Guideline for Clinical Trials of New Patent Chinese Medicines[M]. Beijing: China medical science and technology press， 2002:116-119.
[13]	范金柱，杨柳，罗卓荆，等. 雌激素对绝经后骨质疏松患者骨髓间充质干细胞Notch信号通路的影响[J]. 中华骨质疏松和骨矿盐疾病杂志，2013，6(3):232-239.
[14]	FAN JZ， YANG L， LUO ZJ， et al. Impact of estrogen on the Notch signaling pathway in human bone mesenchymal stem cells derived from patients with postmenopausal osteoporosis[J]. Chin J Osteopor Bone Mineral Res， 2013， 6(3):232-239.
[15]	陈壹. 乳铁蛋白对去卵巢大鼠骨量及骨组织IGF-1、IGFBP-3和IGFBP-5表达的影响[D].福州：福建医科大学，2015.
[16]	CHEN Y. Effects of Lactoferrin on Bone Mass and Expressions of IGF-1， IGFBP-3 and IGFBP-5 of Bone Tissue in Ovariectomized Rats[D]. Fuzhou: Fujian Medical University， 2015.
[17]	杨力，蔡德鸿，汤灵丽. 绝经后骨质疏松与相关骨代谢指标关系的研究[J]. 广东医学，2005，5(26):624-626.
[18]	YANG L， CAI DH， TANG LL. Relationship between postmenopausal osteoporosis and bone metabolic markers[J]. Guangdong Med J， 2005， 5(26):624-626.